Skip to Content

News

Stay informed about important news from Terumo Interventional Systems, including new product introductions, tradeshow events, learning opportunities, and more.

Page 2 of 6
  • Mar 20, 2023

    Prospective, Multi-Center, Single-Arm Study Demonstrates Effectiveness of Terumo Medical Corporation’s Cross-Seal™ Suture-Mediated Vascular Closure Device (VCD) System


  • Mar 07, 2023

    Terumo Prospective Registry Reinforces Safety, Efficacy and Efficiency of Radial Access in Visceral Interventions (R.A.V.I.) in Embolization Procedures


  • Nov 01, 2022

    New Randomized Controlled Study Published in JAMA Demonstrates the Value of Clinical Decision Support Tools in Preventing Acute Kidney Injury in Patients Undergoing Coronary Angiography


  • Mar 31, 2022

    Terumo Launches New ‘Terumo Medical Care Solutions’ Brand


  • Feb 25, 2022

    Corazon and Terumo Sign Collaboration and Co-Marketing Agreement


  • Jan 11, 2022

    Terumo Medical Corporation Applauds ACC/AHA/SCAI Decision to Designate Radial Access Class 1, Level of Evidence A


  • Dec 16, 2021

    Terumo Announces 5-Year Growth Strategy (GS26) to Deliver Solutions to 21st Century Healthcare Challenges


  • Sep 17, 2021

    Terumo Celebrates 100th Anniversary of Contributing to Society Through Healthcare


  • May 14, 2021

    Terumo Donates Additional USD 1 Million to Support the COVID-19 Solidarity Response Fund for WHO - Contributions will Help Bolster Vaccine Equity